 In Hong Kong, Joanne Wong, Bloomberg Radio. And it is now seven and a half minutes past the hour. Eli Lilly has agreed to buy U.S. gut drug maker Morphic for about $3.2 billion. Lilly will pay $57 a share in cash for Morphic, or 79% more than the closing price on Friday.